Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’
Drug Discovery World
JANUARY 21, 2024
Bushell will discuss the history and technological underpinnings of induced proximity, the lessons learned from the PROTAC (proteolysis-targeting chimeric) example, and how technology can create enhancement-targeting chimeric, or ENTAC, drugs and fully realise the potential of targeted protein enhancement. Is pharma’s commercial model dying?
Let's personalize your content